Government of Canada
Symbol of the Government of Canada

Common menu bar links

The NRC Publications Archive is now operational; however, not all the features of the site are available at this time.

The following features remain unavailable:

  • Viewing/Downloading of full text publications
  • Author browse feature
  • Affiliation/institute/portfolio search
  • NRC Publication Archive statistics

NRC is currently working to restore these features and we will update this notice as these features become available. Thank you for your patience.


 
 
 
 

Successful compensation for dystrophin deficiency by a helper-dependent adenovirus expressing full-length utrophin

 
 
Affiliation:
NRC Biotechnology Research Institute; National Research Council Canada
Language:
English
Type:
Article
Published in:
Molecular Therapy
Date:
2007
Pages :
1767-1774
NRCC #:
47807
Identifier #:
47807
NPArC #:
3539215
Keywords:
Animal; animals; bio; deficiency; dna; dystrophin; mice; muscles; phenotype; protein; proteins; therapy
Abstract:
Helper-dependent adenovirus vector (AdV)–mediated full-length dystrophin expression leads to significant mitigation of the dystrophic phenotype of the mdx mouse. However, dystrophin, as a neoantigen, elicits antibody formation. As an alternative approach, we evaluated gene transfer of full-length murine utrophin, a functional homologue of dystrophin that is normally present only at the neuromuscular junction. A single injection in the tibialis anterior (TA) muscle of the helper-dependent adenovirus vector encoding utrophin provided very good transduction, with 58% of fibers demonstrating sarcolemmal utrophin expression in the neonates, and 35% utrophin-positive (Utr⁺) fibers in adults. The presence of utrophin prevented extensive necrosis in the neonates, halted further necrosis in the adults, and led to restoration of sarcolemmal expression of dystrophin-associated proteins up to 1 year after injection. Marked physiological improvement was observed in both neonates and adults. Neither increased humoral responses nor cellular immune responses were evident. However, there was a time-related decline of the initial high utrophin expression. Although viral DNA persisted in animals that were injected in the neonatal stage, viral DNA levels decreased in muscles of adult mice. These results demonstrate that although utrophin gene transfer leads to amelioration of the dystrophic phenotype, the effects are not sustained upon loss of utrophin expression.
 
Bookmark and Share:
 
 
 
 
Link:
HTML Link: